Nualtra’s innovative weight control product Altralife chosen for major NHS contract

Published 08 September 2020

Nualtra has been selected as a preferred partner to supply product to the NHS in the UK for a ground-breaking diet programme for patients with Type 2 Diabetes.
Nualtra will supply its innovative weight control product Altralife, which is made in Ireland, to the 5,000 NHS Type 2 Diabetes patients taking part in the programme, across the UK, which is commencing this month.

This follows a further successful contract in the UK, where Nualtra reached an agreement with ICS Health & Wellbeing to supply Altralife to 10,000 further patients under the North West London Clinical Commissioning Group. The patients are participants in ICS Health & Wellbeing’s REWIND programme, which is also aimed at people with Type 2 Diabetes.

As well as further penetration into the UK market, it is Nualtra’s plan to launch Altralife shakes and soup mix in Ireland, to help Irish patients with Type 2 Diabetes and to reduce the significant cost which the condition places on the Irish healthcare system. The total cost to the Irish healthcare system of managing Diabetes is estimated at €2 billion per annum, of which type 2 diabetes accounts for €400-500m. These numbers will continue to grow unless addressed, as obesity rates increase.

The company believes that there is the potential to roll out a similar study in Ireland, in partnership with the HSE and Enterprise Ireland’s Innovation Partnership Programme.
Nualtra was founded in 2012 by Paul Gough. It is a medical nutrition company focused on the delivery of affordable Oral Nutritional Supplements (ONS). Supported by Enterprise Ireland, the company is the fastest growing of its kind in the UK and Ireland.

Developed by Nualtra, Altralife is a Total Diet Replacement that is nutritionally complete and is intended to replace all food in the first 12 weeks of the 12-month NHS programme. Participants are encouraged to try a soup and shakes weight-loss plan and will cease taking all diabetes medication at the commencement of the programme. This follows a successful trial by NHS England, which saw almost half of participants experience remission after a year.

Paul Gough, Founder of Nualtra said: “We are very proud to announce our recent UK expansion and partnerships with the NHS and ICS Health & Wellbeing. The demand for Altralife from these leading organisations is a testament to the time and effort invested by our team in developing it. Altralife was created with a focus on great-tasting products with modern, lifestyle branding that aims to remove the stigma often associated with weight loss and weight control products. We believe it will be extremely beneficial for diabetes patients in Ireland and the UK”.

William Hadfield, Clinical Dietetic Lead with ICS Health & Wellbeing said “This ground-breaking programme now offers people living with Type 2 diabetes a new option. We no longer have to rely on medications to manage blood glucose levels – we give people the tools to take control and manage Type 2 diabetes in their own way. This is going to revolutionise the way we manage Type 2 diabetes.”

Listen to Nualtra founder Paul Gough's interview with Limerick's Live 95 below: